PL448864A1 - Selenium and zinc concentration in biological material as a marker of survival in patients with kidney cancer in Poland - Google Patents

Selenium and zinc concentration in biological material as a marker of survival in patients with kidney cancer in Poland

Info

Publication number
PL448864A1
PL448864A1 PL448864A PL44886424A PL448864A1 PL 448864 A1 PL448864 A1 PL 448864A1 PL 448864 A PL448864 A PL 448864A PL 44886424 A PL44886424 A PL 44886424A PL 448864 A1 PL448864 A1 PL 448864A1
Authority
PL
Poland
Prior art keywords
selenium
patients
kidney cancer
poland
survival
Prior art date
Application number
PL448864A
Other languages
Polish (pl)
Inventor
Elżbieta Złowocka-Perłowska
Piotr Baszuk
Wojciech MARCINIAK
Aleksandra Tołoczko-Grabarek
Marcin Słojewski
Artur Lemiński
Michał Soczawa
Milena Matuszczak
Adam Kiljańczyk
Jan LUBIŃSKI
Róża Derkacz
Original Assignee
Read-Gene Spółka Akcyjna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Read-Gene Spółka Akcyjna filed Critical Read-Gene Spółka Akcyjna
Priority to PL448864A priority Critical patent/PL448864A1/en
Publication of PL448864A1 publication Critical patent/PL448864A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Nieoczekiwanie ustalono, że istnieje korelacja między stężeniem selenu oraz cynku we krwi pełnej oraz w surowicy a ryzykiem zgonu pacjentów ze zdiagnozowanym rakiem nerki. Nieoczekiwanie zaobserwowano, że pacjenci z rakiem nerki oraz niskimi stężeniami selenu i cynku we krwi pełnej oraz w surowicy wykazują zwiększone ryzyko zgonu w stosunku do pacjentów z wyższymi stężeniami selenu oraz cynku. Dodatkowo nieoczekiwanie ustalono, że istnieje korelacja pomiędzy stosunkiem stężeń cynku do selenu (Zn/Se) we krwi pełnej oraz w surowicy a ryzykiem zgonu pacjentów ze zdiagnozowanym rakiem nerki.Surprisingly, a correlation was found between the concentration of selenium and zinc in whole blood and serum and the risk of death in patients diagnosed with kidney cancer. Surprisingly, kidney cancer patients with low selenium and zinc concentrations in whole blood and serum were found to have an increased risk of death compared to patients with higher selenium and zinc concentrations. Additionally, a correlation was found between the zinc to selenium (Zn/Se) ratio in whole blood and serum and the risk of death in patients diagnosed with kidney cancer.

PL448864A 2024-06-17 2024-06-17 Selenium and zinc concentration in biological material as a marker of survival in patients with kidney cancer in Poland PL448864A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL448864A PL448864A1 (en) 2024-06-17 2024-06-17 Selenium and zinc concentration in biological material as a marker of survival in patients with kidney cancer in Poland

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL448864A PL448864A1 (en) 2024-06-17 2024-06-17 Selenium and zinc concentration in biological material as a marker of survival in patients with kidney cancer in Poland

Publications (1)

Publication Number Publication Date
PL448864A1 true PL448864A1 (en) 2025-12-22

Family

ID=98212002

Family Applications (1)

Application Number Title Priority Date Filing Date
PL448864A PL448864A1 (en) 2024-06-17 2024-06-17 Selenium and zinc concentration in biological material as a marker of survival in patients with kidney cancer in Poland

Country Status (1)

Country Link
PL (1) PL448864A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL436999A1 (en) * 2021-02-15 2022-08-16 Read-Gene Spółka Akcyjna Serum copper concentration as a prognostic marker in patients with prostate cancer in Poland
PL437046A1 (en) * 2021-02-18 2022-08-22 Read-Gene Spółka Akcyjna Serum arsenic, zinc and selenium concentration as a marker of survival in patients with prostate cancer in Poland

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL436999A1 (en) * 2021-02-15 2022-08-16 Read-Gene Spółka Akcyjna Serum copper concentration as a prognostic marker in patients with prostate cancer in Poland
PL437046A1 (en) * 2021-02-18 2022-08-22 Read-Gene Spółka Akcyjna Serum arsenic, zinc and selenium concentration as a marker of survival in patients with prostate cancer in Poland

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LUBIŃSKI J, ET AL.: "Nutrients. 2023 Jun 2;15(11):2611", SERUM ESSENTIAL ELEMENTS AND SURVIVAL AFTER CANCER DIAGNOSIS *
MEYER HA, ET AL.: "PLoS One.2012;7(10):e46644", SELENOPROTEIN P STATUS CORRELATES TO CANCER-SPECIFIC MORTALITY IN RENAL CANCER PATIENTS *

Similar Documents

Publication Publication Date Title
Gabriel et al. Influence of sex, source, health status and acclimation on the haematology of Clarias gariepinus (Burch, 1822)
Ince et al. Protective effects of boron on cyclophosphamide induced lipid peroxidation and genotoxicity in rats
Zabłocka-Słowińska et al. Serum and whole blood Zn, Cu and Mn profiles and their relation to redox status in lung cancer patients
Cox et al. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation
Lu et al. Microorganism-enabled photosynthetic oxygeneration and ferroptosis induction reshape tumor microenvironment for augmented nanodynamic therapy
Garg et al. An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis
Baltaci et al. Selenium: Its metabolism and relation to exercise.
EP1597353A4 (en) CIRCULATING TUMOR CELLS (CTC): EARLY EVALUATION OF EVOLUTION TIME, SURVIVAL AND REACTION TO THERAPIES OF METASTASIC CANCER PATIENTS
Gajdosechova et al. Possible link between Hg and Cd accumulation in the brain of long-finned pilot whales (Globicephala melas)
PL440972A1 (en) Method of determining the risk of cancer in women depending on the ratio of selenium to arsenic concentrations in blood
Sloper Presence of a substance rich in protein-bound cystine or cysteine in the neurosecretory system of an insect
Perottoni et al. Effects of mercury and selenite on δ-aminolevulinate dehydratase activity and on selected oxidative stress parameters in rats
Marshall et al. The 50 year evolution of in vitro systems to reveal salt transport functions of teleost fish gills
Sharma et al. Serum mineral and haematobiochemical profile of microfilariae infected cattle in India: Its effects on production and therapy
Kadam et al. Evaluation of serum levels of reduced glutathione, glutathione-s-transferase and nitric oxide in breast cancer patients undergoing adjuvant chemotherapy
Iwamoto et al. Upper hemibody infusion of cis-diamminedichloroplatinum (II) followed by systemic antidote, sodium thiosulfate, for lung metastasis in rats
Charniot et al. Oxidative stress implication in a new ex-vivo cardiac concordant xenotransplantation model
Costa et al. Cell kinetics: an independent prognostic variable in stage II melanoma of the skin
Drobyshev et al. Toxic or beneficial? What is the role of food‐relevant selenium species selenoneine?
ElSaid et al. Investigation on the effects of copper deficiency on fertility and some hematobiochemical parameters in rams with trial for treatment
Timoshin et al. Estimation of nitric oxide level in vivo by microdialysis with water-soluble iron-N-methyl-d-dithiocarbamate complexes as NO traps: A novel approach to nitric oxide spin trapping in animal tissues
PL449871A1 (en) Copper-to-zinc ratio in serum as a biomarker of survival in patients with prostate cancer
Sujatha Devi et al. Study on the Effect of Artemia Franciscana on the Uptake of Zn (II) and Cu (II)
MICLI et al. THE STUDY OF GLYCOPROTEINS FROM PLASMA AT BITCHES AND CATS WITH MAMMARY TUMORS
Patil et al. Onion toxicosis in buffaloes